Cardiac autonomic neuropathy in diabetic patients: Influence of diabetes duration, obesity, and microangiopathic complications - The French multicenter study

Metabolism: Clinical and Experimental

Volumn 52, Issue 7, 2003, Pages 815-820

  Valensi, Paul ^a,b   Paries J ^a   Attali, Jean Raymond ^a,b   Cathelineau, Gérard ^a,c   Fossati, Pierre ^a,d   Verier Mine, Odile ^a,d   Monnier, Louis ^a,e   Pouget, Jean Yves ^a,f   Vague, Philippe ^a,f   Leutenegger, Marc ^a,g   Lubetzki, Jean ^a,h   Duet, Michèle ^a,h   Brogard, Jean Marie ^a,i   Paris, Dominique ^a,i  

^a UNIVERSITÉ PARIS 13   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d Regional Hospital and University Center   (France)

^e La Peyronie Hospital   (France)

^f TIMONE HOSPITAL   (France)

^g SERVICE DE DERMATOLOGIE   (France)

^h HÔPITAL LARIBOISIÈRE   (France)

ⁱ HÔPITAL CIVIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; FRUCTOSAMINE; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; ARTICLE; AUTONOMIC NEUROPATHY; BODY MASS; BODY POSITION; BREATHING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FRANCE; HEART RATE VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; STANDARDIZATION; VALSALVA MANEUVER;

EID: 0043092313     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00095-7     Document Type: Article

References (55)

1. Ewing DJ, Campbell IW, Clarke BF: The natural history of diabetic autonomic neuropathy. Q J Med 49:95-108, 1980
2. Ziegler D: Diabetic cardiovascular autonomic neuropathy. Prognosis, diagnosis and treatment. Diabetes Metab Rev 10:339-383, 1994
3. Ewing DJ, Campbell JW, Clarke BF: Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med 92:308-311, 1980
4. Wieling W, Van Brederode JFM, De Rijk LG, et al: Reflex control of heart rate in normal subjects in relation to age: A data base for cardiac vagal neuropathy. Diabetologia 22:163-166, 1992
5. O'Brien IAD, O'Hare P, Corral RJM: Heart rate variability in healthy subjects: Effect of age and the derivation of normal ranges for tests of autonomic function. Br Heart J 55:348-354, 1986
6. Armstrong KM, Bradbury JE, Ellis SH, et al: A study of peripheral diabetic neuropathy. The application of age-related reference values. Diabet Med 8:S94-S99, 1991 (suppl)
7. Belmin J, Valensi P: Diabetic neuropathy in elderly patients. What can be done? Drugs Aging 6:416-429, 1996
8. Valensi P, Attali J.R, Gagant S: Reproducibility of parameters for assessment of diabetic neuropathy. Diabet Med 10:933-939, 1993
9. Ewing DJ, Martyn CN, Young RJ, et al: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8:491-498, 1985
10. Pfeifer MA, Weinberg CR, Cook DL, et al: Correlations among autonomic, sensory, and motor neural function tests in untreated non-insulin dependent diabetic individuals. Diabet Care 8:576-584, 1985
11. Valensi P, Attali JR, Sachs RN, et al: Intérêt comparé de l'enregistrement ECG des 24 h et des manoeuvres standardisées dans la détection et l'exploration de la neuropathie autonome cardiaque chez le diabétique. Diabetes Med 13:205-209, 1987
12. Valensi P, Huard JP, Giroux C, et al: Factors involved in cardiac autonomic neuropathy in diabetic patients. J Diabetes Complications 11:180-187, 1997
13. Fraser DM, Campbell JW, Ewing DJ, et al: Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus. Diabetes 26:546-550, 1977
14. Pfeifer MA, Weinberg CR, Cook DL, et al: Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 7:447-453, 1984
15. Ziegler D, Cicmir I, Mayer P, et al: Peripheral and autonomic nerve dysfunction in newly diagnosed insulin-dependent diabetes. Transplant Proc 18:1593-1594, 1986
16. McDaid EA, Hayes JR, Monaghan B, et al: Peripheral autonomic impairment in patients newly diagnosed with type II diabetes. Diabetes Care 17:1422-1427, 1994
17. The Diabetes Control and Complications Trial (DCCT): Design and methodologic considerations for the feasibility phase. Diabetes 35:530-545, 1986
18. Hillson RM, Hockaday TDR, Newton DJ: Hyperglycaemia is one correlate of deterioration in vibration sense during 5 years after diagnosis of type 2 (non-insulin-dependent) diabetes. Diabetologia 26:122-126, 1984
19. Young RJ, McIntyre CCA, Martyn CN, et al: Progression of subclinical polyneuropathy in young patients with type 1 (insulin-dependent) diabetes: Associations with glycaemic control and microangiopathy (microvascular complications). Diabetologia 29:156-161, 1986
20. Graf RJ, Halter JB, Pfeifer MA, et al: Glycemic control and nerve conduction abnormalties in non-insulin-dependent diabetic subjects. Ann Intern Med 94:307-311, 1981
21. Jakobsen J, Christiansen JS, Kristoffensen I, et al: Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes 37:452-455, 1988
22. The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 122:561-568, 1995
23. Valensi P, Ngoc PTB, Lormeau B, et al: Cardiac autonomic function in the obese patients. Int J Obes 19:113-118, 1995
24. Bergstrom B, Lilja B, Osterlin S, et al: Autonomic neuropathy in non-insulin-dependent (type II) diabetes mellitus: Possible influence of obesity. J Intern Med 227:57-63, 1990
25. Maser RE, Steenkiste AR, Dorman JS, et al: Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetic Complications Study. Diabetes 38:1456-1461, 1989
26. McCulloch DK, Campbell IW, Prescott RJ, et al: Effect of alcohol intake on symptomatic peripheral neuropathy in diabetic men. Diabetes Care 3:245-247, 1980
27. The DCCT Research Group: Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes 37:476-481, 1988
28. Krolewski AS, Berzilay J, Warram JH, et al: Risk of early-onset proliferative retinopathy in IDDM is closerly related to cardiovascular autonomic neuropathy. Diabetes 41:430-437, 1992
29. Molgaard H, Christensen PD, Sorensen KE, et al: Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM patients. Diabetes 41:812-817, 1992
30. Ziegler D, Gries FA, Mühlen H, et al: Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. Diabetes Metab 19:143-151, 1993
31. O'Brien IAD, O'Hare JP, Lewin IG, et al: The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: A controlled study based on heart rate variability. Q J Med 61:957-967, 1986
32. Valensi P: La dysautonomie diabétique. Gravité, méthodes de détection, tentatives thérapeutiques. Ann Med Int (Paris) 142:31-41, 1991
33. Smith SE: AUTOCAFT. Lancet 2:772, 1988
34. Valensi P, Attali JR: Pourquoi et comment faut-il rechercher une neuropathie autonome cardiovasculaire chez les diabétiques? Diabetes Metab 23:351-356, 1997
35. SPSS: SPSS/PS + Advanced Statistics. V 4.0 1. Chicago, IL, SPSS, 1992
36. Spallone V, Barini A, Gambardella S, et al: Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patient. Diabetes Care 17: 578-584, 1994
37. Bergström B, Lilja B, Osterlin S, et al: Autonomic neuropathy in type 1 diabetes: Influence of duration and other diabetic complications. Acta Med Scand 222:147-154, 1987
38. Masaoka S, Lev-Ran A, Hill LR, et al: Heart rate variability in diabetes: Relationship to age and duration of the disease. Diabetes Care 8:64-68, 1985
39. Lehtinen JM, Niskanen L, Hyvönen K, et al: Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus and in control subjects. A 5-year follow-up. Diabetologia 36:68-72, 1993
40. Brown FM, Brink SJ, Freeman R, et al: Anti-sympathetic nervous system antibodies. Diminished catecholamines with orthostasis. Diabetes 38:938-941, 1989
41. Dyrberg T, Benn J, Sandahl Christiansen J, et al: Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia 20:190-194, 1981
42. Sibony-Prat J, Pariès J, Chabert M, et al: Altération du contrôle vagosympathique cardiovasculaire évalué par l'analyse spectrale des variations de fréquence cardiaque et de pression artérielle chez les obèses. Arch Mal Coeur Vaisseaux 8:1155-1158, 1997
43. Valensi P, Smagghue O, Pariès J, et al: Impairment of skin vasoconstrictive response to sympathetic activation in obese patients: Influence of rheological disorders. Metabolism 49:600-606, 2000
44. Peterson HR, Rothschild M, Weinberg CR, et al: Body fat and the activity of the autonomic nervous system. N Engl J Med 318: 1077-1083, 1988
45. Hirsch JA, Bishop B: Respiratory sinus arthythmia in humans: How breathing pattern modulates heart rate. Am J Physiol 241:H620-H629, 1981
46. Straub RH, Palitzsch KD, Thum M, et al: Impact of obesity on neuropathic late complications in NIDDM. Diabetes Care 17:1290-1294, 1994
47. Smith SE, Smith SA, Brown PM: Cardiac autonomic dysfunction in patients with diabetic retinopathy. Diabetologia 21:525-528, 1981
48. Clark CV: Autonomic neuropathy in proliferative diabetic retinopathy. Eye 1:496-499, 1987
49. Ferrari-Dileo G, Davis EB, Anderson DR: Angiotensin binding sites in bovine and human retinal blood vessels. Invest. Ophthalmol Vis Sci 28:1747-1751, 1987
50. Greene DA, Lattimer SA, Sima AAF: Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316:599-606, 1987
51. Vinores SA, Campochiaro PA, Williams EH, et al: Aldose reductase expression in human diabetic retina and retinal pigment epithelium. Diabetes 37:1658-1664, 1988
52. Pelayo JC, Quan AH: Neurogenic control of renal function, in Massry SG, Glassock RJ (eds): Textbook of Nephrology (ed 2). Baltimore, MD, Williams & Wilkins, 1989, pp 65-69
53. Sundkvist G, Lilja B: Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 16:773-779, 1993
54. Borch-Johnsen K, Andersen P, Deckert T: The effect of proteinuria on relative mortality in type 1 (insulin dependent) diabetes mellitus. Diabetologia 28:590-595, 1985
55. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, et al: Coronary heart disease in young type 1 (insulin dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors. Diabetologia 30:144-148, 1987